Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
10(53%)
Results Posted
17%(1 trials)

Phase Distribution

Ph phase_3
13
68%
Ph phase_4
5
26%

Phase Distribution

0

Early Stage

0

Mid Stage

18

Late Stage

Phase Distribution18 total trials
Phase 3Large-scale testing
13(72.2%)
Phase 4Post-market surveillance
5(27.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

10

trials recruiting

Total Trials

19

all time

Status Distribution
Active(10)
Completed(6)
Other(3)

Detailed Status

Recruiting10
Completed6
unknown3

Development Timeline

Analytics

Development Status

Total Trials
19
Active
10
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 313 (72.2%)
Phase 45 (27.8%)

Trials by Status

unknown316%
completed632%
recruiting1053%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT06691191Phase 4

Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors

Recruiting
NCT05997693Phase 3

One-Month DAPT in CABG Patients

Recruiting
NCT06591377Phase 3

Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA

Recruiting
NCT06591338Phase 3

Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIA

Recruiting
NCT06318481Phase 3

TADCLOT- a Double Blind Randomized Controlled Trial

Completed
NCT06509893Phase 4

Ticagrelore Alone Post PCI

Recruiting
NCT06591312Phase 3

Combining Aspirin With Ticagrelor or Clopidogrel in Minor Stroke or TIA

Recruiting
NCT06591390Phase 3

Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIA

Recruiting
NCT06196047Phase 3

Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA

Recruiting
NCT06202755Phase 3

Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke

Recruiting
NCT06561867Phase 3

Ticagrelor Versus Cilostazol in Ischemic Stroke

Recruiting
NCT06120725Phase 3

Ticagrelor Versus Clopidogrel in Large Vessel Ischemic Stroke

Completed
NCT03251859Phase 3

Effectiveness of Lower Maintenance Dose of Ticagrelor Early After Myocardial Infarction (ELECTRA) Pilot Study

Completed
NCT05183178Phase 4

Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome

Unknown
NCT03444012

ADHERE-S (NIS Brilique)

Completed
NCT02086903Phase 3

Clopidogrel And Ticagrelor in Healthy Subjects

Completed
NCT03620760Phase 4

Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation

Unknown
NCT03614832Phase 4

Ticagrelor and Clopidogrel on Platelet Aggregation in Clopidogrel Resistance's Patients With CHD

Unknown
NCT01225562Phase 3

Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin

Completed

All 19 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
19